299 related articles for article (PubMed ID: 22266551)
41. Prognostic impact of histology in patients with cervical squamous cell carcinoma, adenocarcinoma and small cell neuroendocrine carcinoma.
Intaraphet S; Kasatpibal N; Siriaunkgul S; Sogaard M; Patumanond J; Khunamornpong S; Chandacham A; Suprasert P
Asian Pac J Cancer Prev; 2013; 14(9):5355-60. PubMed ID: 24175825
[TBL] [Abstract][Full Text] [Related]
42. LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix.
Hedman H; Lindström AK; Tot T; Stendahl U; Henriksson R; Hellberg D
Acta Oncol; 2010 Aug; 49(6):812-5. PubMed ID: 20553099
[TBL] [Abstract][Full Text] [Related]
43. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
[TBL] [Abstract][Full Text] [Related]
44. Adenocarcinoma histology is a poor prognostic factor in locally advanced cervical cancer.
Jonska-Gmyrek J; Gmyrek L; Zolciak-Siwinska A; Kowalska M; Kotowicz B
Curr Med Res Opin; 2019 Apr; 35(4):595-601. PubMed ID: 30019594
[TBL] [Abstract][Full Text] [Related]
45. Influence of treatment center and hospital volume on survival for locally advanced cervical cancer.
Wright JD; Huang Y; Ananth CV; Tergas AI; Duffy C; Deutsch I; Burke WM; Hou JY; Neugut AI; Hershman DL
Gynecol Oncol; 2015 Dec; 139(3):506-12. PubMed ID: 26177552
[TBL] [Abstract][Full Text] [Related]
46. Recent trends in histological pattern of cervical carcinoma among three ethnic groups in Malaysia.
Cheah PL; Looi LM; Sivanesaratnam V
J Obstet Gynaecol Res; 1999 Dec; 25(6):401-6. PubMed ID: 10680337
[TBL] [Abstract][Full Text] [Related]
47. FIGO 2018 stage IB endocervical adenocarcinomas: an international study of outcomes informed by prognostic biomarkers.
Stolnicu S; Boros M; Hoang L; Almadani N; de Brot L; Baiocchi G; Bonvolim G; Parra-Herran C; Lerias S; Felix A; Roma A; Pesci A; Oliva E; Park K; Soslow RA; Abu-Rustum NR
Int J Gynecol Cancer; 2021 Feb; 31(2):177-184. PubMed ID: 33177150
[TBL] [Abstract][Full Text] [Related]
48. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
[TBL] [Abstract][Full Text] [Related]
49. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
[TBL] [Abstract][Full Text] [Related]
50. Impact of histology on prognosis of patients with early-stage cervical cancer treated with radical surgery.
Rudtanasudjatum K; Charoenkwan K; Khunamornpong S; Siriaunkgul S
Int J Gynaecol Obstet; 2011 Nov; 115(2):183-7. PubMed ID: 21885048
[TBL] [Abstract][Full Text] [Related]
51. Comparing mortality of vaginal sarcoma, squamous cell carcinoma, and adenocarcinoma in the surveillance, epidemiology, and end results database.
Ghezelayagh T; Rauh-Hain JA; Growdon WB
Obstet Gynecol; 2015 Jun; 125(6):1353-1361. PubMed ID: 26000506
[TBL] [Abstract][Full Text] [Related]
52. High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma.
Samuels S; Ferns DM; Meijer D; van Straalen JP; Buist MR; Zijlmans HJ; Kenter GG; Jordanova ES
Tissue Antigens; 2015 Jun; 85(6):476-83. PubMed ID: 25871737
[TBL] [Abstract][Full Text] [Related]
53. Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy alone.
Matsuo K; Nusbaum DJ; Machida H; Huang Y; Khetan V; Matsuzaki S; Klar M; Grubbs BH; Roman LD; Wright JD
Am J Obstet Gynecol; 2020 May; 222(5):484.e1-484.e15. PubMed ID: 31678092
[TBL] [Abstract][Full Text] [Related]
54. [Does adenocarcinoma of uterine cervix have a worse prognosis than squamous carcinoma?].
Recoules-Arche A; Rouzier R; Rey A; Villefranque V; Haie-Meder C; Pautier P; Pomel C; Lhommé C; Duvillard P; Castaigne D; Morice P
Gynecol Obstet Fertil; 2004 Feb; 32(2):116-21. PubMed ID: 15123133
[TBL] [Abstract][Full Text] [Related]
55. Poor prognosis in patients with adenosquamous cell carcinoma of the cervix.
Gallup DG; Harper RH; Stock RJ
Obstet Gynecol; 1985 Mar; 65(3):416-22. PubMed ID: 3974967
[TBL] [Abstract][Full Text] [Related]
56. Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma. MIB-1 and PC10 labeling indices.
Oka K; Nakano T; Hoshi T
Cancer; 1996 Jun; 77(11):2280-5. PubMed ID: 8635096
[TBL] [Abstract][Full Text] [Related]
57. A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer.
Xie X; Song K; Cui B; Jiang J; Yang X; Kong B
Int J Clin Oncol; 2018 Jun; 23(3):522-531. PubMed ID: 29299705
[TBL] [Abstract][Full Text] [Related]
58. Effect of hydronephrosis on survival in advanced stage cervical cancer.
Goklu MR; Seckin KD; Togrul C; Goklu Y; Tahaoglu AE; Oz M; Ertas IE
Asian Pac J Cancer Prev; 2015; 16(10):4219-22. PubMed ID: 26028076
[TBL] [Abstract][Full Text] [Related]
59. Prognostic value of histopathology and trends in cervical cancer: a SEER population study.
Vinh-Hung V; Bourgain C; Vlastos G; Cserni G; De Ridder M; Storme G; Vlastos AT
BMC Cancer; 2007 Aug; 7():164. PubMed ID: 17718897
[TBL] [Abstract][Full Text] [Related]
60. Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?
Ayhan A; Aslan K; Bulut AN; Akilli H; Öz M; Haberal A; Meydanli MM
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():209-214. PubMed ID: 31325847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]